Advasa Holdings, Inc. has taken a significant step by announcing a reverse stock split, which aims to adjust its share structure and ensure compliance with Nasdaq listing standards. This decision, approved by a majority of shareholders, reflects the company's strategic efforts to stabilize its stock performance and enhance its market position.
Based in Tokyo, Japan, Advasa Holdings operates under the SIC code 7372, which pertains to Services-Prepackaged Software. The company is listed on the Nasdaq under the ticker symbol ADBT. Recent filings indicate that Advasa is an emerging growth company, actively engaging in corporate actions to optimize its operations.
The recent filing, dated November 5, 2026, outlines the approval of a reverse stock split by the board of directors following a written consent from shareholders holding approximately 75% of the company's voting power. The filing states, "The actions approved grant the Board discretionary authority... to effect a reverse stock split of the issued and outstanding shares of the Company’s common stock, at a ratio in the range of 1-for-10 to 1-for-100." This move is designed to address the volatility of Advasa's common stock and to help maintain compliance with Nasdaq's continued listing standards.
The reverse stock split is expected to impact shareholders by consolidating their shares, which could potentially increase the stock price per share. However, the exact ratio and timing of the split will be determined at the discretion of the board of directors. The filing clarifies that no further action or approval from other shareholders is required, as the necessary consent has already been obtained from the majority stockholders.
Looking ahead, the reverse stock split will become effective no sooner than 20 calendar days after the Definitive Information Statement is mailed to shareholders. The company has not specified a date for this mailing, but it is anticipated to occur shortly, allowing the board to implement the split promptly.
Read Next
FMR LLC Amends 13F Filing, Revealing Key Holdings
Digital Turbine names Daniel Lentz CFO, effective Nov. 2
AIM ImmunoTech announces Ampligen opportunities in new filing
Invesco files summary prospectus for new ETF focused on growth
Summit Asset Management Reports $776.5 Million in Holdings
AIR Global PLC submits FDA application for Crown Switch vape









